Slilaty Steve N. 4
4 · Sunshine Biopharma, Inc · Filed Feb 12, 2024
Insider Transaction Report
Form 4
Slilaty Steve N.
DirectorCEO and President10% Owner
Transactions
- Purchase
Series B Preferred Stock
2024-02-08$0.10/sh+20,000$2,000→ 30,000 total
4 · Sunshine Biopharma, Inc · Filed Feb 12, 2024
Series B Preferred Stock